---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-062162"
form_type: "8-K"
ticker: "GANX"
cik: "0001819411"
company_name: "Gain Therapeutics, Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:52:45.624130+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Gain Therapeutics stockholders approve doubling authorized common stock to 100M shares

## Summary
- Stockholders approved amendment to increase authorized common shares from 50M to 100M.
- All eight director nominees elected; Ernst & Young AG ratified as auditor for FY2025.
- Vote results: 16.3M for share increase, 2.2M against, 12k abstain; 18.0M ratified auditor.
- Adjournment proposal also approved to allow further proxy solicitation if needed.

## SEC filing metadata
- accession: 0001104659-25-062162
- form_type: 8-K
- ticker: GANX
- cik: 0001819411
- company_name: Gain Therapeutics, Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819411/000110465925062162/0001104659-25-062162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819411/000110465925062162/tm2518700d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-062162
- JSON: https://secwatch.observer/filing/0001104659-25-062162.json
- Plain text: https://secwatch.observer/filing/0001104659-25-062162.txt

## Key facts
- Governance Changes
  Gain Therapeutics, Inc.: Increased authorized shares of common stock from 50,000,000 to 100,000,000 (effective 2025-06-24).
  - Change: charter amendment
  - Effective: 2025-06-24
  source text: On June 24, 2025, Gain Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock from 50,000,000 shares to 100,000,000 shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819411/000110465925062162/0001104659-25-062162-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.